The Center's Annual Conference
on Precision Psychiatry
The Center for Precision Psychiatry hosts an annual conference every autumn. This conference, hosted by the Center, the Mass General Department of Psychiatry, and the Psychiatry Academy, has already begun to become a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. So far, the conference has drawn an average of 1,000 registrants and has featured outstanding speakers.
Our third conference, "Innovation to Implementation", will be held virtually on September 29th and 30th, 2023. We’re pleased that this year’s conference will feature Keynotes by Dr. John Krystal, Chair of the Department of Psychiatry at Yale University, and Dr. Helen Mayberg, Director of The Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai.
The conference is designed to cover a broad range of domains including:
- Applications of AI & machine learning in psychiatry
- Genomics and other "-omics"
- Precision therapeutics
- Risk stratification for suicide and other important outcomes
- mHealth and digital technologies
- Implementation science
- Ethics and equity
2022: Second Annual Conference
Our second Annual Conference, "Innovation to Implementation", was held virtually on November 2nd and November 3rd, 2022. The Conference was held in partnership with the Mass General Department of Psychiatry and the Psychiatric and Neurodevelopmental Genetics Unit in the Mass General Center for Genomic Medicine. The conference featured keynote addresses from Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022).
2021: First Annual Conference
Our first Annual Conference, "The Promise of Precision Predication, Prevention, and Treatment in Mental Health", was held virtually on September 30th and October 1st, 2021. The Conference was held in partnership with the Mass General Department of Psychiatry and the Psychiatric and Neurodevelopmental Genetics Unit in the Mass General Center for Genomic Medicine. The Conference featured a Keynote address from Dr. Joshua Gordon, and an opening plenary from Dr. Joshua Denny.